Biotricity, Inc. - Statements of Stockholders' Deficiency - USD ($)	12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Balance, Value	$ (4,384,816)	$ (2,569,979)
Issuance of shares for private placement, Value	5,181,325	1,367,573
Issuance of warrants for private placement investors	(3,183,614)	(339,308)
Issuance costs - broker warrants	(385,635)	(104,627)
Conversion of convertible notes into common, Value		3,108,767
Issuance of shares for services, Value	1,922,906	817,355
Exercise of warrants for cash, Value	428,311	105,500
Issuance of warrants for services	370,358	876,438
Stock based compensation - ESOP	1,002,201	626,136
Cash issuance costs	(320,351)	(129,650)
Translation adjustment	(229,745)	(333,731)
Net loss for the year	(8,623,738)	(7,809,290)
Adjustment to derivative liabilities upon adoption of ASU 2017-11	4,052,773
Conversion of convertible notes into common shares, Value	4,357,697
Balance, Value	173,247	(4,384,816)
Preferred Stock
Balance, Value	$ 1	$ 1
Balance, Shares	1	1
Balance, Value	$ 1	$ 1
Balance, Shares	1	1
Common stock and exchangeable common shares
Balance, Value	$ 27,199	$ 25,000
Balance, Shares	27,198,872	24,999,978
Issuance of shares for private placement, Value	$ 1,996	$ 781
Issuance of shares for private placement, Shares	1,996,119	781,480
Conversion of convertible notes into common, Value		$ 913
Conversion of convertible notes into common, Shares		912,652
Issuance of shares for services, Value	$ 528	$ 374
Issuance of shares for services, Shares	527,941	373,397
Exercise of warrants for cash, Value	$ 253	$ 131
Exercise of warrants for cash, Shares	252,798	131,365
Cashless exercise of warrants, Value	$ 59
Cashless exercise of warrants, Shares	58,795
Conversion of convertible notes into common shares, Value	$ 1,823
Conversion of convertible notes into common shares, Shares	1,823,014
Balance, Value	$ 31,858	$ 27,199
Balance, Shares	31,857,539	27,198,872
Shares to be Issued
Conversion of convertible notes into common, Value		$ 200,855
Conversion of convertible notes into common, Shares		77,463
Issuance of shares for services, Value	$ 83,588	$ (200,855)
Issuance of shares for services, Shares	20,250	(77,463)
Balance, Value	$ 69,963
Balance, Shares	20,250
Additional Paid-in Capital
Balance, Value	$ 14,308,583	$ 7,982,465
Issuance of shares for private placement, Value	5,179,329	1,366,791
Issuance of warrants for private placement investors	(3,183,614)	(339,308)
Issuance costs - broker warrants	(385,635)	(104,627)
Conversion of convertible notes into common, Value		2,906,999
Issuance of shares for services, Value	1,837,990	1,017,837
Exercise of warrants for cash, Value	428,058	105,369
Issuance of warrants for services	370,358	876,438
Stock based compensation - ESOP	1,002,201	626,136
Cash issuance costs	(320,351)	(129,650)
Translation adjustment		133
Adjustment to derivative liabilities upon adoption of ASU 2017-11	3,569,250
Cashless exercise of warrants, Value	(59)
Conversion of convertible notes into common shares, Value	4,355,874
Balance, Value	27,161,984	14,308,583
Accumulated other comprehensive (loss) income
Balance, Value	(413,384)	(79,520)
Translation adjustment	(229,745)	(333,864)
Balance, Value	(643,129)	(413,384)
Retained Deficit
Balance, Value	(18,307,215)	(10,497,925)
Net loss for the year	(8,623,738)	(7,809,290)
Adjustment to derivative liabilities upon adoption of ASU 2017-11	483,523
Balance, Value	$ (26,447,430)	$ (18,307,215)